Literature DB >> 17593188

Arrhythmogenic right ventricular dysplasia:clinical study.

Grazyna Markiewicz-Łoskot1, Ewa Moric-Janiszewska, Maria Loskot, Lesław Szydłowski, Andrzej Hollek, Ludmiła Weglarz.   

Abstract

Arrhythmogenic right ventricular dysplasia (ARVD) is a complex arrhythmogenic cardiomyopathy, characterized by a partial or total replacement of the right ventricular myocytes by fatty and fibrous tissue. In this study, we present a case of ARVD in 17 year old girl, who was admitted to the hospital after syncope with ventricular arrhythmia. The echocardiography did not demonstrate structural cardiac abnormalities but the magnetic resonance recently showed thinning of the right ventricular wall. The girl was treated with the lidocaine, amiodarone and next, after radiofrequency catheter ablation she was receiving metoprolol. The girl has remained asymptomatic for four years of follow-up.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17593188      PMCID： PMC6932165          DOI： 10.1111/j.1542-474X.2007.00158.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN： 1082-720X            Impact factor:   1.468


  12 in total

1.  Electrocardiographic and echocardiographic abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy and in their pedigrees.

Authors:  N Yoshioka; K Tsuchihashi; S Yuda; A Hashimoto; K Uno; T Nakata; K Shimamoto
Journal:  Am J Cardiol       Date:  2000-04-01       Impact factor: 2.778

2.  MR evaluation of arrhythmogenic right ventricular cardiomyopathy in pediatric patients.

Authors:  Galit Aviram; Joel E Fishman; Ming-Lon Young; Esmail Redha; Gurur Biliciler-Denktas; Maria M Rodriguez
Journal:  AJR Am J Roentgenol       Date:  2003-04       Impact factor: 3.959

3.  Right bundle branch block, right precordial st-segment elevation, and sudden death in young people.

Authors:  D Corrado; C Basso; G Buja; A Nava; L Rossi; G Thiene
Journal:  Circulation       Date:  2001-02-06       Impact factor: 29.690

4.  Right ventricular cardiomyopathy and sudden death in young people.

Authors:  G Thiene; A Nava; D Corrado; L Rossi; N Pennelli
Journal:  N Engl J Med       Date:  1988-01-21       Impact factor: 91.245

5.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

Authors:  P Richardson; W McKenna; M Bristow; B Maisch; B Mautner; J O'Connell; E Olsen; G Thiene; J Goodwin; I Gyarfas; I Martin; P Nordet
Journal:  Circulation       Date:  1996-03-01       Impact factor: 29.690

6.  Clinical and familial study of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Q Shan; K Cao; Y Huang; M Liao; M Chen; W Li; J Zou; B Zhu; W Ma
Journal:  Chin Med J (Engl)       Date:  2001-04       Impact factor: 2.628

7.  Cardiac arrest and sudden death in competitive athletes with arrhythmogenic right ventricular dysplasia.

Authors:  F Furlanello; A Bertoldi; M Dallago; C Furlanello; F Fernando; G Inama; C Pappone; S Chierchia
Journal:  Pacing Clin Electrophysiol       Date:  1998-01       Impact factor: 1.976

8.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Jean-Jacques Blanc; Andrzej Budaj; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Eur Heart J       Date:  2006-09       Impact factor: 29.983

9.  High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification.

Authors:  Hein Heidbüchel; Jan Hoogsteen; Robert Fagard; L Vanhees; Hugo Ector; Rik Willems; Johan Van Lierde
Journal:  Eur Heart J       Date:  2003-08       Impact factor: 29.983

10.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study.

Authors:  D Corrado; C Basso; G Thiene; W J McKenna; M J Davies; F Fontaliran; A Nava; F Silvestri; C Blomstrom-Lundqvist; E K Wlodarska; G Fontaine; F Camerini
Journal:  J Am Coll Cardiol       Date:  1997-11-15       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.